Nationwide Fund Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,428
Closed -$162K 171
2017
Q3
$162K Sell
5,428
-357
-6% -$9.77K ﹤0.01% 2720
2017
Q2
$135K Hold
5,785
﹤0.01% 2776
2017
Q1
$126K Sell
5,785
-757
-12% -$17.1K ﹤0.01% 2769
2016
Q4
$148K Hold
6,542
﹤0.01% 2739
2016
Q3
$150K Hold
6,542
﹤0.01% 2764
2016
Q2
$140K Sell
6,542
-1,993
-23% -$62.8K ﹤0.01% 2779
2016
Q1
$314K Hold
8,535
﹤0.01% 2317
2015
Q4
$235K Buy
8,535
+171
+2% +$4.68K ﹤0.01% 2465
2015
Q3
$250K Hold
8,364
﹤0.01% 2459
2015
Q2
$352K Buy
+8,364
New +$395K ﹤0.01% 2434

Other funds holding ATEX

Nationwide Fund Advisors's ATEX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Anterix (ATEX) in Q4 2017, closing a stake of 5,428 shares — an estimated $162K sold.

Nationwide Fund Advisors first reported a position in ATEX in Q2 2015 and held it in 10 quarters. The position peaked at $352K in Q2 2015. 52 funds tracked by Wall St. Rank hold ATEX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Anterix position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 5,428 Anterix shares in Q4 2017, an estimated $162K.
  • Nationwide Fund Advisors first reported a position in Anterix in Q2 2015 and held it in 10 quarters.
  • Nationwide Fund Advisors's Anterix position peaked at $352K in Q2 2015.
  • 52 funds tracked by Wall St. Rank held Anterix as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.